企業概要
Welltower Inc. operates within the real estate sector, specifically focusing on the REIT - Healthcare Facilities industry by providing rental housing for aging seniors across the United States, United Kingdom, and Canada. This positioning places the company at the center of the silver economy, where its portfolio of over 2,000 seniors and wellness housing communities bridges the gap between traditional housing and healthcare services. The enterprise possesses a substantial scale, evidenced by a market capitalization of $142.83B and an annual revenue of $10.84B over the trailing twelve months. With an employee base of 712, the company's significant market cap and multi-billion dollar revenue stream indicate a dominant market position and extensive operational reach within the senior housing sector.
財務健全性
The company reported a revenue of $10.84B, net income of $936.84M, and EBITDA of $2.66B for the trailing twelve months. The substantial gap between the total revenue of $10.84B and the net income of $936.84M reveals a cost structure where operating expenses, including interest on debt and property management costs, consume a significant portion of gross earnings before reaching the bottom line. The free cash flow stands at $2.29B, which provides the entity with considerable financial flexibility to service debt obligations, fund capital expenditures, or return capital to shareholders without compromising liquidity. However, the gross margin of 40.2% contrasts sharply with the operating margin of -28.2%, indicating that while revenue generation is efficient, operating costs and interest expenses are currently eroding profitability at the operational level before tax and financing effects are fully considered. The profit margin is reported at 8.6%, suggesting that after all expenses are accounted for, the company retains a fraction of revenue as net earnings. In terms of leverage, the company holds $5.03B in cash against $21.38B in total debt, resulting in a debt-to-equity ratio of 49.49, which characterizes the balance sheet as highly leveraged given the magnitude of debt relative to equity. The current ratio of 1.70 indicates that the company possesses sufficient short-term assets to cover its short-term liabilities, providing a buffer for immediate operational needs. Furthermore, the return on equity is 2.5% and the return on assets is 0.6%, metrics that reveal management effectiveness is currently low, as the capital invested is generating minimal returns relative to the book value of equity and total assets.
バリュエーション評価
The valuation metrics present a complex picture, with a trailing P/E ratio of 145.18 compared to a forward P/E of 62.22. The significant disparity between the trailing P/E of 145.18 and the forward P/E of 62.22 implies that the market expects earnings to increase dramatically in the future to justify the current high multiple, or that current earnings are temporarily depressed. The price-to-book ratio is 3.38, indicating that the stock trades at a substantial premium over its book value, reflecting market expectations of high growth or intangible assets not captured on the balance sheet. Alternative valuation metrics such as the price-to-sales ratio of 13.18 and the EV/EBITDA of 60.14 suggest that the company is priced aggressively relative to its sales and earnings power, which is typical for REITs in the healthcare sector but warrants careful scrutiny against peer group averages. The 52-week high is $216.43 and the 52-week low is $130.29, meaning the stock is trading within a wide historical range that reflects significant price volatility over the past year. The beta of 0.82 indicates that the stock's price volatility is lower than the broader market, suggesting it may be less sensitive to general market swings compared to the S&P 500 average.
Growth & Income
The financial growth trajectory shows a revenue growth of 41.3% year-over-year, while earnings growth is negative at -26.3%. This divergence indicates that earnings are growing much slower than revenue, or in this specific instance, have contracted despite revenue expansion, implying that cost increases or one-time charges are impacting the bottom line more severely than top-line sales are growing. As a dividend payer, the company offers a dividend yield of 1.4% with a payout ratio of 198.6%, which raises questions about sustainability as the payout exceeds the reported earnings. This high payout ratio suggests the company is distributing more cash than its net income supports, potentially relying on free cash flow or debt reduction to maintain dividend payments. Overall, the growth and income profile presents a scenario of rapid revenue expansion offset by earnings contraction and a dividend payout that exceeds current earnings capacity.